Heads M&A strategy, pipeline, and execution including diligence, valuation, and deal closing.
Owns post-close integration planning and cross-functional leadership to realize deal value.
Partners on de novo development and strategic partnerships to scale operations.
Groups provides value-based addiction care, expanding its clinical model into new states and markets. As an executive team member, this leader drives M&A and strategic growth in a mission-driven organization.
Drive end-to-end M&A deal execution including target evaluation, financial modeling, due diligence, and transaction structuring.
Build and manage a repeatable acquisition pipeline with disciplined CRM and playbooks to support 10+ quality acquisitions annually.
Partner cross-functionally with finance, legal, HR, and operations to ensure smooth deal handoffs and post-close integration.
Scientific Safety Alliance (SSA) accelerates life sciences innovation by removing operational friction for pharmaceutical, biotech, hospital, and research facilities. SSA is a 100% founder- and employee-owned company that has created over $300M in enterprise value through disciplined growth and 21 acquisitions, and it continues to be recognized as one of the fastest growing privately held companies.
Apply your financial expertise to enhance the quality and reliability of AI-generated financial content by creating and refining prompts and case studies.
Evaluate AI outputs for accuracy in valuation, modeling, forecasting, and financial reasoning, identifying errors and providing structured feedback.
Collaborate with distributed project teams to ensure consistent quality standards and timely delivery of complex financial analyses.
This role is listed on behalf of a partner company, who manages all applications and next steps. The work is fully remote and designed for specialists who enjoy analytical problem-solving in a fast-evolving environment.